
NuVasive, Inc.
(NUVA)
Monteverde & Associates Announces the Investigation of NuVasive, Inc.

Cardiovascular Systems, Inc.
(CSII)
Monteverde & Associates Announces the Investigation of Cardiovascular Systems, Inc.

Sumo Logic, Inc.
(SUMO)
Monteverde & Associates Announces the Investigation of Sumo Logic, Inc.

Oak Street Health, Inc.
(OSH)
Monteverde & Associates Announces the Investigation of Oak Street Health, Inc.

Argo Group International Holdings, Ltd.
(ARGO)
Monteverde & Associates Announces the Investigation of Argo Group International Holdings, Ltd.

AlerisLife Inc.
(ALR)
Monteverde & Associates Announces the Investigation of AlerisLife Inc.

Chembio Diagnostics, Inc.
(CEMI)
Monteverde & Associates Announces the Investigation of Chembio Diagnostics, Inc.

Atlas Technical Consultants, Inc.
(ATCX)
Monteverde & Associates Announces the Investigation of Atlas Technical Consultants, Inc.

Concert Pharmaceuticals, Inc.
(CNCE)
Monteverde & Associates Announces the Investigation of Concert Pharmaceuticals, Inc.

Leap Therapeutics, Inc.
(LPTX)
Monteverde & Associates Announces the Investigation of Leap Therapeutics, Inc.



Angion Biomedica Corp.
(ANGN)
Monteverde & Associates Announces the Investigation of Angion Biomedica Corp.

Golden Matrix Group, Inc.
(GMGI)
Monteverde & Associates Announces the Investigation of Golden Matrix Group, Inc.

Duck Creek Technologies, Inc.
(DCT)
Monteverde & Associates Announces the Investigation of Duck Creek Technologies, Inc.

Paya Holdings Inc.
(PAYA)
Monteverde & Associates Announces the Investigation of Paya Holdings Inc.